Table 4.
Baseline characteristics of the study population with or without a diagnosis of liver cirrhosis
| Total (n=1,944) | Liver cirrhosis (-) (n=1,382) | Liver cirrhosis (+) (n=562) | P-value | |
|---|---|---|---|---|
| Age (years) | 48 (37–57) | 45 (34–55) | 53 (45–61) | <0.001 |
| Males | 1,135 (58.35) | 763 (55.21) | 372 (66.07) | <0.001 |
| WBC (103/µL) | 5,700 (4,500–7,040) | 5,995 (4,800–7,300) | 5,070 (3,905–6,500) | <0.001 |
| Hemoglobin (g/dL) | 13.05±1.97 | 13.29±1.92 | 12.46±1.99 | <0.001 |
| Platelets (103/µL) | 200 (146–251) | 220 (175–263) | 137 (92–194) | <0.001 |
| Total bilirubin (mg/dL) | 0.82 (0.59–1.26) | 0.76 (0.56–1.13) | 0.97 (0.72–1.47) | <0.001 |
| Albumin (g/dL) | 3.92±0.56 | 4.03±0.51 | 3.64±0.57 | <0.001 |
| AST (U/L) | 51 (31–94) | 51 (29–100) | 50 (34–86) | 0.537 |
| ALT (U/L) | 48 (24–110) | 58 (26–147) | 34 (21–57) | <0.001 |
| Creatinine (mg/dL) | 1.02±0.97 | 1.02±0.97 | 1.03±0.97 | 0.820 |
| PT (INR) | 1.08±0.16 | 1.05±0.14 | 1.17±0.19 | <0.001 |
| Ascites | <0.001 | |||
| None | 1,784 (91.72) | 1,335 (96.6) | 449 (79.75) | |
| Mild | 137 (7.04) | 43 (3.11) | 94 (16.7) | |
| Moderate to severe | 24 (1.23) | 4 (0.29) | 20 (3.55) | |
| Child-Pugh class | ||||
| Class A | N/A | N/A | 413 (73.36) | |
| Class B or C | N/A | N/A | 150 (26.64) | |
| MELD | N/A | N/A | 8.75 (7.6–10.59) | |
| Complication | 1 | 0 | 1 | 0.289 |
Values are presented as mean±standard deviation, median (range) for continuous variables, or frequency (percentage) for categorical variables. The proportions are presented as percentages for categorical variables.
WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PT, prothrombin time; INR, international normalized ratio; N/A, not applicable; MELD, model for end-stage liver disease.